BLSI Cancer news pretty good and the stock showing nice buying could be a monday gapper after retail buyers read the news
Friday February 5, 2:38 pm Eastern Time
Boston Life says molecule may halt tumors
BOSTON, Feb 5 (Reuters) - Boston Life Sciences Inc (Nasdaq:BLSI - news) said Friday its researches inadvertently identified a
molecule in the human body that could be used to prevent the growth of tumors in cancer patients.
While preparing another protein, Troponin, for human testing to treat tumor growth and eye diseases, the researchers said they identified another protein that may be
even more powerful.
''We identified a second molecule that looks even better than Troponin,'' Dr. Marc Lanser, founder and chief scientific officer of Boston Life Sciences, told Reuters.
Troponin is scheduled to begin human testing within five months, Lanser said.
Troponin and the as-yet-unnamed second molecule are both anti-angiogenic agents that could prevent tumors from growing by cutting off their blood supply.
The process is important, Lanser said, because many cancer patients end up dying from metastatic tumors, or metastases. Metastases are secondary tumors, related
to the first, that attack the body long after the initial cancer has been removed.
For example, a colon cancer removed from a patient can reappear and kill the patient five years later when it returns in the form of metastases that have grown
throughout the body.
''It's a potentially non-toxic approach to the treatment of all tumor growth,'' Lanser said. Both molecules occur naturally in the body, but are not plentiful enough to
suffocate the tumors on their own.
Lanser said the molecule identified earlier this week could be ready for human testing within a year if clinical tests confirm it may be more potent than Troponin or
that it could work in conjunction with Troponin. The company next step is for the company to seek a patent, make more of the molecules and conduct animal testing.
''We're very encouraged,'' Lanser said.
Boston Life's stock was up 1/16 at 5, in early afternoon trading.
More Quotes and News:
Boston Life Sciences Inc (Nasdaq:BLSI - news)
Related News Categories: health, US Market News |
